CEPT (PF3D7_0628300) is an endoplasmic reticulum-localized choline/ethanolaminephosphotransferase that catalyzes the terminal step of de novo phosphatidylcholine biosynthesis in Plasmodium and is essential for asexual blood-stage development (PMID:20478340, PMID:22471905). In P. berghei the gene is refractory to knockout, and GFP-tagging localizes the protein to the ER, distinguishing it from the cytosolic upstream Kennedy-pathway enzymes; sequence analysis confirms the catalytic domains and residues required for phosphotransferase activity (PMID:20478340). In P. falciparum, CEPT displays CDP-choline phosphotransferase activity with a Km of ~13 µM and is the primary molecular target of the antimalarial albitiazolium, which inhibits the enzyme in vitro and directly engages CEPT in living parasites as shown by competitive photocrosslinking with a clickable albitiazolium probe that co-localizes to the ER and trans-Golgi (PMID:22471905, PMID:25470252). CEPT protein levels fall upon pharmacological disruption of phospholipid synthesis without a matching transcriptional change, indicating post-transcriptional/post-translational regulation (PMID:18973684). Co-immunoprecipitation places CEPT in physical association with phosphatidylserine synthase at the ER (PMID:35623558), and its locus is marked by repressive H3K36me2/3 in stage II gametocytes, correlating with stage-specific transcriptional silencing (PMID:33794978). Beyond these findings, no further mechanistic detail on CEPT has been characterized in the available corpus.